|
|
|
|
Vol. 56, Issue 5, 1042-1046, November 1999
Laboratory of Biochemistry, School of Medicine, University of
Patras, Patras, Greece
In a cell-free system derived from Escherichia coli,
lincomycin produces biphasic logarithmic time plots for inhibition of peptide-bond formation when puromycin is used as an acceptor substrate and AcPhe-tRNA as a donor substrate. In a previous study, initial slope
analysis of the logarithmic time plots revealed that the encounter
complex CI between the initiator ribosomal complex (C) and lincomycin
(I) undergoes a slow isomerization to C*I. During this change, the
bound AcPhe-tRNA and lincomycin are rearranged to also accommodate
puromycin, and this may account for the mixed noncompetitive inhibition
(Ki* = 70 µM) established at higher concentrations of the drug. The above-mentioned effect was further investigated by analyzing the late phase of the logarithmic time plots.
It was found that C*I complex reacts with a second molecule of I,
giving C*I2 complex. However, the logarithmic time plots remain biphasic even at high concentrations of lincomycin, making possible the identification of another inhibition constant
Ki*', which is equal to 18 µM. The
simplest explanation of this finding is to assume the existence of a
second isomerization step C*I2
C*I2', slowly equilibrated. The determination
of Ki*' enables us to calculate the
isomerization constant (Kisom = 2.9)
with the formula Ki*' = Ki*/(1 + Kisom).
Our results suggest that whenever a fast and reversible interaction of
lincomycin with the elongating ribosomal complex C occurs, the latter
undergoes a slow isomerization, which may be the result of
conformational changes induced by the drug.
This article has been cited by other articles:
![]() |
J. Meurer, L. Lezhneva, K. Amann, M. Godel, S. Bezhani, I. Sherameti, and R. Oelmuller A Peptide Chain Release Factor 2 Affects the Stability of UGA-Containing Transcripts in Arabidopsis Chloroplasts PLANT CELL, December 1, 2002; 14(12): 3255 - 3269. [Abstract] [Full Text] [PDF] |
||||